NatureWise Biotech & Medicals Corporation (TPEX:4732)

TPEX:4732 Revenue

NatureWise Biotech & Medicals had revenue of 86.77M TWD in the half year ending June 30, 2025, with 30.75% growth. This brings the company's revenue in the last twelve months to 180.29M, down -19.72% year-over-year. In the year 2024, NatureWise Biotech & Medicals had annual revenue of 224.32M with 40.08% growth.

• Revenue (ttm): 180.29M
• Revenue Growth: -19.72%
• P/S Ratio: 5.24
• Revenue / Employee: 5.63M
• Employees: 32
• Market Cap: 944.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	224.32M	64.18M	40.08%
Dec 31, 2023	160.14M	-68.45M	-29.94%
Dec 31, 2022	228.59M	-21.21M	-8.49%
Dec 31, 2021	249.80M	-57.12M	-18.61%
Dec 31, 2020	306.92M	-546.00K	-0.18%